Award
National Institute of General Medical Sciences 11329917
Topical treatment for burn pain by blocking cutaneous pain receptors.
Recipient
SERENTRIX, LLC
Award Amount
$6,500.00
Ceiling
$6,500.00
Awarded
September 02, 2025
Identifier
11329917
Award for developing a non-opioid topical therapy targeting peripheral pain receptors to manage burn pain, aiming to reduce opioid dependency and improve patient outcomes.
Description
Development of a first-in-class, non-opioid topical formulation targeting TRPV1 for burn pain management. Supports commercialization activities to translate research into a therapeutic product. The project aims to develop a safe, effective treatment to improve patient outcomes and reduce opioid reliance.